- About Lung Cancer
- Support & Resources
- Make a Difference
UPDATE: December 20, 2012
WE ARE ANOTHER STEP CLOSER! Today, the House of Representatives passed the National Defense Authorization Act of 2013 Conference Report. This legislation includes the Recalcitrant Cancer Research Act, legislation creating new National Cancer Institute (NCI) scientific frameworks for the most lethal cancers. Lung and Pancreatic cancers are given priority status in the bill. The United States Senate is expected to approve the conference shortly thereafter, at which point, the legislation will be sent to President Obama for signature.
The Recalcitrant Cancer Research Act of 2012 requires NCI, within 18 months, to carry out a complete inventory of all research done to date, overlooked areas, the availability of researchers and the impact on public health. Then, they are to develop a scientific framework for a comprehensive plan of research action to address all aspects of the cancer including prevention, diagnosis and treatment.
Within 30 days of its development, the scientific framework must be sent to Congress and made publicly available.
We hope the Senate will act quickly and send this bill to President Obama for signature before Christmas. This would be a truly wonderful holiday gift to the entire lung cancer community that has worked so hard to accomplish this core priority.